is Chemoradiation-induced changes in systemic inflammatory markers and their prognostic significance in oesophageal squamous cell carcinoma

被引:2
作者
Khin, Ni Sann [1 ]
Tan, Sze Huey [2 ]
Wang, Michael Lc [1 ]
Slow, Tian Rui [1 ]
Lim, Faye Lwt [1 ]
Wang, Fu Qiang [1 ]
Ng, Matthew Ch [3 ]
Lam, Justina Yc [3 ]
Yip, Connie [1 ]
机构
[1] Natl Canc Ctr Singapore, Dept Radiat Oncol, 11 Hosp Dr, Singapore, Singapore
[2] Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Sci, 11 Hosp Dr, Singapore, Singapore
[3] Natl Canc Ctr Singapore, Dept Med Oncol, 11 Hosp Dr, Singapore, Singapore
关键词
TO-LYMPHOCYTE RATIO; CANCER; CHEMORADIOTHERAPY; NEUTROPHIL; CACHEXIA; OUTCOMES;
D O I
10.1259/bjr.20200314
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Chemoradiation (CRT) may induce a change in systemic inflammatory state which could affect clinical outcomes in oesophageal cancer. We aimed to evaluate the changes and prognostic significance of systemic inflammatory markers following definitive CRT in oesophageal squamous cell carcinoma. Methods: A total of 53 patients treated with concurrent CRT were included in this retrospective analysis. We compared neutrophils, lymphocytes, platelets, neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) before and after CRT using Wilcoxon signed-rank test. Overall survival (OS) and progression-free survival (PFS) were calculated. Univariable and multivariable survival analysis were performed using Cox regression analysis. Clinical univariable survival prognostic factors with p < 0.1 were included in a multivariable cox regression analysis for backward stepwise model selection. Results: Both NLR (median Delta+2.8 [IQR-0.11, 8.62], p < 001) and PLR (median Delta+227 [81.3-523.5], p < 0.001) increased significantly after CRT. Higher levels of pre-CRT, post-CRT and change (Delta) in NLR and PLR were associated with inferior OS and PFS. Post-CRT NLR (HR 1.04, 95% CI 1.02-1.07, p < 0.001), post-CRT platelets (HR 1.03, 95% CI 1.01-1.05, p = 0.005), cT-stage (HR 3.83, 95% CI 1.39-10.60, p = 0.01) and RT dose (HR 0.41, 95% CI 0.21-0.81, p = 0.01) were independent prognostic factors for OS in multivariable analysis. Change in NLR (HR 1.04, 95% CI 1.01-1.06, p = 0.001), post-CRT platelets (HR 1.03, 95% CI 1.01-1.05, p = 0.002), cT-stage (HR 3.98, 95% CI 1.55-10.25, p = 0.004) and RT dose (HR 0.41, 95% CI 0.210.80, p = 0.009) were independent prognostic factors for PFS. Conclusion: Both NLR and PLR increased following definitive CRT. Post-CRT NLR and Delta NLR were associated with adverse survival in oesophageal SCC. Advances in knowledge: We showed that CRT increased PLR and NLR, possibly reflecting a systemic inflammatory state which were associated with poor clinical outcomes in oesophageal SCC.
引用
收藏
页数:8
相关论文
共 25 条
[1]   Cancer cachexia: understanding the molecular basis [J].
Argiles, Josep M. ;
Busquets, Silvia ;
Stemmler, Britta ;
Lopez-Soriano, Francisco J. .
NATURE REVIEWS CANCER, 2014, 14 (11) :754-762
[2]   Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial [J].
Chen, Yun ;
Ye, Jinjun ;
Zhu, Zhengfei ;
Zhao, Weixin ;
Zhou, Jialiang ;
Wu, Chaoyang ;
Tang, Huarong ;
Fan, Min ;
Li, Ling ;
Lin, Qin ;
Xia, Yi ;
Li, Yunhai ;
Li, Jiancheng ;
Jia, Huixun ;
Lu, Saiquan ;
Zhang, Zhen ;
Zhao, Kuaile .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (20) :1695-+
[3]   Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01) [J].
Cooper, JS ;
Guo, MD ;
Herskovic, A ;
Macdonald, JS ;
Martenson, JA ;
Al-Sarraf, M ;
Byhardt, R ;
Russell, AH ;
Beitler, JJ ;
Spencer, S ;
Asbell, SO ;
Graham, MV ;
Leichman, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1623-1627
[4]   The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy [J].
Cox, Samantha ;
Hurt, Christopher ;
Grenader, Tal ;
Mukherjee, Somnath ;
Bridgewater, John ;
Crosby, Thomas .
RADIOTHERAPY AND ONCOLOGY, 2017, 125 (01) :154-159
[5]   Systemic inflammation, cachexia and prognosis in patients with cancer [J].
Deans, C ;
Wigmore, SJ .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (03) :265-269
[6]   The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis [J].
Dolan, Ross D. ;
McSorley, Stephen T. ;
Horgan, Paul G. ;
Laird, Barry ;
McMillan, Donald C. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 116 :134-146
[7]   High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer [J].
Fang, Penny ;
Jiang, Wen ;
Davuluri, Rajayogesh ;
Xu, Cai ;
Krishnan, Sunil ;
Mohan, Radhe ;
Koong, Albert C. ;
Hsu, Charles C. ;
Lin, Steven H. .
RADIOTHERAPY AND ONCOLOGY, 2018, 128 (03) :584-590
[8]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[9]   The Platelet Lifeline to Cancer: Challenges and Opportunities [J].
Haemmerle, Monika ;
Stone, Rebecca L. ;
Menter, David G. ;
Afshar-Kharghan, Vahid ;
Sood, Anil K. .
CANCER CELL, 2018, 33 (06) :965-983
[10]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674